Ambulatory Laparoscopic Inguinal Hernioplasty: Feasibility and Cost Analysis

November 27, 2020 updated by: Hospital Italiano de Buenos Aires

Ambulatory Laparoscopic Inguinal Hernioplasty: Feasibility and Cost Minimization Analysis in a South American Hospital

Laparoscopic inguinal hernia repair has become one of the elective techniques, attributing the advantages of minimally invasive procedures to it. However, the high costs related to the need for hospitalization and materials make them a limitation at the time of its indication.

The objective is to evaluate the feasibility of performing this procedure in an outpatient surgery center and the cost analysis of an outpatient procedure regarding the same in the setting of hospitalization.

Study Overview

Status

Completed

Conditions

Detailed Description

A retrospective analysis was performed on a prospective database in which all patients older than 18 years were included, in which a laparoscopic inguinal hernioplasty was performed in the period between August 2015 and June 2018 in the unit of ambulatory surgery of the Hospital Italiano de Buenos Aires. The same corresponds to an autonomous unit controlled by a health facility with hospitalization, as established by the Asociación Argentina de Cirugía in the Organization Guide and procedures in Ambulatory Surgery.

Laparoscopic repair using a transabdominal preperitoneal technique (TAPP) was proposed for patients with a clinical diagnosis of bilateral inguinal hernia or a recurrent unilateral hernia operated primarily through the anterior approach following the indications for laparoscopic surgery proposed by the European Hernia Society

The demographic data of the patients considered for this study were: age, gender, body mass index (BMI), anesthetic risk according to ASA (American Society of Anesthesiologists) score, comorbidities, bilateral primary or unilateral recurrent hernia, history of previous abdominal surgeries and associated midline hernias The details of the surgical procedure and the ambulatory surgery regimen, as well as possible postoperative complications, were explained to all patients in the preoperative consultation and an informed consent was signed.

The anesthetic technique was the same for everyone. The patients were operated under general anesthesia. Anesthetic induction was performed with propofol 2 mg / kg EV and fentanyl 2 ug / kg EV. Rocuronium 0.6 mg / kg EV was used to facilitate laryngeal mask placement. The anesthetic level was maintained with air, oxygen, sevoflorane at 1.5% expired and with remifentanil (0.25 at 0.5 ug / kg / min) based on the demand of the patient's plan. It was ventilated mechanically in controlled mode. As intraoperative analgesia, ketorolac 1 mg / kg according to renal function or diclofenac 1 mg / kg was used in patients with a history of bronchospasm. This was associated with 8 mg of dexamethasone. Antibiotic prophylaxis during anesthetic induction was performed with cefazolin 2 gr / kg EV.

In 100% of the cases, the surgical technique used was TAPP. The patient was asked to urinate prior to the transfer to the operating room to avoid the placement of a urinary catheter.

With the patient in the supine position, pneumoperitoneum was performed by umbilical scar with closed Veress needle technique. The abdomen was insufflated with a pressure of 12 mmHg. A 10-mm trocar was placed at the umbilical level and two 5-mm trocars were placed on both flanks outside the rectus sheath. In the event that the patient presents with an associated midline hernia, optic trocar was inserted due to hernia defect. It was approached first on one side and then on the contralateral side. After the opening of the peritoneum, dissection of the preperitoneal space and reduction of the hernial content, a polypropylene mesh (Prolene®, Ethicon Johnson & Johnson) of 15 x 12 centimeters was placed covering the myopectineal orifice from the symphysis pubis medially, until the anterosuperior iliac spine laterally. In patients with bilateral hernia, two meshes were placed, one on each side respectively, surpassing the midline. The mesh was fixed with tuckers made of resorbable material (Securetrap®) or unabsorbable material (Protack®) according to the preference of the surgeon in charge of the procedure. The peritoneum was closed with continuous suture of slow absorbable material (Vycril®) or slow reabsorbed barb suture (Stratafix®). Local infiltration of all wounds was performed with ropivacaine at a dose of 3 mg / kg.

Surgical time was recorded as intraoperative variables, which was defined as minutes from the preparation of the surgical site to the closure of the skin; the type of hernia according to Nyhus classification and the presence of intraoperative complications.

At the end of the procedure, the patients were transferred to the recovery room. During the postoperative recovery an analgesic scheme was stipulated according to need. The rescues were made according to the evaluation of the nurse and the treating anesthetist and consisted of the following levels:

  • First level: ketorolac 30 mg EV or diclofenac 75 mg EV. In patients with decreased glomerular filtration, paracetamol 1000 mg EV was used.
  • Second level: morphine 1 - 3 mg EV. When the requirements of the ambulatory surgery guide of the Asociación Argentina de Cirugía listed in table N° 1 were fulfilled, the patient was discharged from hospital. The same was in charge of the responsible surgeon, who delivered the postoperative indications verbally and in writing, confirming the understanding of them by the patient and the companion.

The length of stay in the unit was recorded, as well as the need to administer analgesics during the same and pain according to the visual analog scale (EVA) at discharge.

Feasibility is expressed as the percentage of patients who were referred from the outpatient surgery unit.

The data about postoperative complications were collected prospectively through ambulatory controls previously stipulated at 7, 30, 180 and 360 days. They are classified into early (up to 30 days of the procedure) and late. The first included seroma, surgical site infection and hematoma; and late trocar hernias, recurrence and postoperative pain. Chronic postoperative pain is one that persists beyond the third month after the procedure.

In the first ambulatory control consultation at 7 days, patients were asked to rate their level of satisfaction with the procedure by choosing one of the four categories: not satisfied, not very satisfied, satisfied and very satisfied For the study of costs in addition to outpatients, those patients who underwent laparoscopic inguinal hernia in the inpatient setting during the period analyzed were included in the analysis. In this way, two branches of study were drawn up, one corresponding to patients operated on an outpatient basis and the other to patients operated through a hospital regimen.

Being a surgical procedure performed under a different hospital regime, a cost minimization study was carried out taking the average cost of performing an ambulatory procedure versus the same requiring admission.

When considering the economic situation of the República Argentina in the time under study (devaluation of the peso argentino weight of 100% and inflation of approximately 30% per year), continuous patients operated between December 2016 and April 2017 were taken, which represents the average of the period under study, as representative samples of each branch. For each patient, the surgical time, the persistence time in the ambulatory anesthetic recovery room or the hospitalization room, and the time of postoperative hospitalization were recorded in a database.

The materials used during surgery and anesthesia were previously standardized so that all the patients who underwent this procedure used the same resources.

The cost department of the Hospital Italiano de Buenos Aires was responsible for collecting the costs of each of these patients. They were divided into fixed costs per procedure, per hour/operating room, per hour in the ambulatory surgery recovery room, per hour in the recovery room of the central operating room and per day of hospitalization.

The costs were calculated in Argentine Pesos (AP) and converted into US Dollars (USD) taking into account the exchange rate in January 2017: 1 USD = 16.30 PA.

The categorical data were described as percentages and the quantitative data as mean and standard deviation or median and interquartile range according to the observed distribution. To compare means of quantitative variables, Student's t-test or Mann-Whitney U test was used according to the observed distribution. Chi-square or Fisher's test was used for the rest of the variables. A p <.05 was considered significant.

Regression models were constructed to adjust for confounding potentials.

Study Type

Observational

Enrollment (Actual)

116

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ciudad de Buenos Aires, Argentina, 1199
        • Hospital Italiano de Buenos Aires

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients older than 18 with no major comorbidities that required a laparoscopic inguinal hernioplasty

Description

  1. Inclusion Criteria:

    • Patients older than 18 years old
    • Laparoscopic inguinal hernioplasty as the pincipal surgery
  2. Exclusion Criteria:

    • Patients with, high anesthetic risk (decompensated ASA III and ASA IV)
    • Morbid obesity (higher BMI 40),
    • Sleep apnea with indication of use of CPAP (Continuous Positive Airway Pressure)
    • Medicated psychiatric disease,
    • Drug-dependent patient
    • Patients with an inadequate social environment-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Laparoscopic Inguinal Hernioplasty. Ambulatory
Laparoscopic Inguinal Hernioplasty performed in ambulatory surgery center
Analyze the feasibility and costs of performing laparoscopic inguinal hernioplasty in an ambulatory surgery center
Laparoscopic Inguinal Hernioplasty. Hospital Stay
Laparoscopic Inguinal Hernioplasty that have to stay at least 24 hours at the hospital
Analyze the feasibility and costs of performing laparoscopic inguinal hernioplasty in an ambulatory surgery center

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of surgical Complications
Time Frame: Patients follow up is 12 month
Incidence of seroma, Incidence of hematoma, % of reoperation, incidence of wound infection
Patients follow up is 12 month
Costs of the procedure
Time Frame: One month after surgery
Cost of laparoscopic hernioplasty in ambulatory surgery center. Cost of laparoscopic hernioplasty when required hospital stay
One month after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Scaravonati, Hospital Italiano de Buenos Aires

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2015

Primary Completion (ACTUAL)

June 30, 2018

Study Completion (ACTUAL)

July 30, 2019

Study Registration Dates

First Submitted

August 5, 2020

First Submitted That Met QC Criteria

August 5, 2020

First Posted (ACTUAL)

August 7, 2020

Study Record Updates

Last Update Posted (ACTUAL)

December 1, 2020

Last Update Submitted That Met QC Criteria

November 27, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 5614

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

I have not decided yet. Maybe some data could be share to other researchers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inguinal Hernia

Clinical Trials on Analysis of feasibility and costs

Subscribe